13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q1 2018. See the latest, Q2 2026 →
Reported value
$306.93B
+4.2% on the quarter before
Positions
4,044
158 new · 145 sold out
Top 10
16.9%
of the value
Est. gain
−$3.85B
on stocks held all quarter
Est. return
−1.3%
on those stocks since Q4 2017
Positions as of Mar 31, 2018, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 28% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2017. Striped tiles are options.
Largest buys
Since Q4 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Booking Holdings Inc~$1.22BNew · 0.0% → 0.4%+586,503 shares
- Microsoft~$440.5MAdded · 2.5% → 2.7%+4,837,419 shares
- Amazon~$349.9MAdded · 1.7% → 2.1%+242,344 shares
- Intel~$269.4MAdded · 0.9% → 1.1%+5,183,304 shares
- Apple~$268.8MAdded · 3.2% → 3.2%+1,605,689 shares
- Berkshire Hathaway Inc-Cl B~$224.4MAdded · 1.4% → 1.4%+1,127,406 shares
- Aflac Inc~$217.5MAdded · 0.1% → 0.1%+4,980,489 shares
- Fiserv Inc~$204.6MAdded · 0.1% → 0.1%+2,874,777 shares
- Johnson & Johnson~$200.5MAdded · 1.4% → 1.3%+1,568,463 shares
- Alphabet~$194.1MAdded · 1.2% → 1.2%+188,596 shares
Largest sells
Since Q4 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Priceline Group Inc/The~$982.3MSold out · 0.3% → 0.0%−566,380 shares
- Vantiv Inc - Cl A~$90.5MSold out · 0.0% → 0.0%−1,230,979 shares
- Scripps Networks Inter-Cl A~$90.0MSold out · 0.0% → 0.0%−1,055,979 shares
- Sensata Technologies Holding~$71.1MSold out · 0.0% → 0.0%−1,391,538 shares
- Bioverativ Inc~$52.3MSold out · 0.0% → 0.0%−969,103 shares
- Healthsouth Corp~$49.2MSold out · 0.0% → 0.0%−995,263 shares
- Calpine Corp~$45.5MSold out · 0.0% → 0.0%−3,010,103 shares
- Liberty Ventures - Ser A~$40.3MSold out · 0.0% → 0.0%−743,850 shares
- Snyders-Lance Inc~$40.0MSold out · 0.0% → 0.0%−799,237 shares
- Calatlantic Group Inc~$36.6MSold out · 0.0% → 0.0%−648,383 shares
Holdings
As of Mar 31, 2018. Changes are in shares against Dec 31, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +2.8% · price −0.9% | 3.2% | $9.72B | −$84.9M | ||||||||
| MicrosoftCOM · shares +5.7% · price +6.7% | 2.7% | $8.21B | +$484.9M | ||||||||
| AmazonCOM · shares +5.7% · price +23.7% | 2.1% | $6.45B | +$1.17B | ||||||||
| Jpmorgan Chase & CoCOM · shares +4.6% · price +2.8% | 1.4% | $4.26B | +$110.7M | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares +5.6% · price +0.6% | 1.4% | $4.23B | +$24.1M | ||||||||
| MetaCL A · shares +4.2% · price −9.5% | 1.4% | $4.22B | −$425.4M | ||||||||
| Johnson & JohnsonCOM · shares +5.1% · price −8.3% | 1.3% | $4.10B | −$353.6M | ||||||||
| AlphabetCAP STK CL C · shares +5.6% · price −1.4% | 1.2% | $3.65B | −$50.4M | ||||||||
| AlphabetCAP STK CL A · shares +5.1% · price −1.6% | 1.2% | $3.57B | −$54.8M | ||||||||
| Exxon Mobil CorpCOM · shares +5.7% · price −10.8% | 1.1% | $3.51B | −$403.1M | ||||||||
| IntelCOM · shares +9.0% · price +12.8% | 1.1% | $3.27B | +$340.5M | ||||||||
| Bank Of America CorpCOM · shares +5.7% · price +1.6% | 1.1% | $3.27B | +$47.4M | ||||||||
| CiscoCOM · shares +8.1% · price +12.0% | 0.84% | $2.58B | +$254.7M | ||||||||
| Wells Fargo & CoCOM · shares +4.0% · price −13.7% | 0.82% | $2.52B | −$382.7M | ||||||||
| Visa Inc.COM CL A · shares +3.3% · price +4.9% | 0.82% | $2.52B | +$113.1M | ||||||||
| AT&TCOM · shares +8.2% · price −8.3% | 0.81% | $2.49B | −$209.4M | ||||||||
| Chevron CorpCOM · shares +7.2% · price −8.9% | 0.79% | $2.42B | −$221.5M | ||||||||
| Pfizer IncCOM · shares +6.0% · price −2.0% | 0.77% | $2.37B | −$46.6M | ||||||||
| Procter & Gamble Co/TheCOM · shares +4.8% · price −13.7% | 0.73% | $2.25B | −$342.5M | ||||||||
| Home Depot IncCOM · shares +7.0% · price −6.0% | 0.72% | $2.22B | −$132.3M | ||||||||
| Unitedhealth Group IncCOM · shares +1.8% · price −3.0% | 0.71% | $2.17B | −$64.8M | ||||||||
| Verizon Communications IncCOM · shares +7.6% · price −9.7% | 0.69% | $2.11B | −$210.2M | ||||||||
| MastercardCL A · shares +3.5% · price +15.7% | 0.64% | $1.98B | +$258.8M | ||||||||
| Boeing Co/TheCOM · shares +3.0% · price +11.1% | 0.64% | $1.96B | +$190.3M | ||||||||
| Citigroup IncCOM NEW · shares +0.1% · price −9.3% | 0.63% | $1.92B | −$197.3M | ||||||||
| Total · 4,044 positions | 100% | $306.93B | −$3.85B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2017 to Q1 2018: 3,832 stocks held throughout, down $3.85B (−1.3%).
- Amazon+$1.17B+24%
- Microsoft+$484.9M+7%
- Netflix+$453.5M+54%
- Intel+$340.5M+13%
- Nvidia+$272.6M+20%
- General Electric Co−$348.3M−23%
- Johnson & Johnson−$353.6M−8%
- Wells Fargo & Co−$382.7M−14%
- Exxon Mobil Corp−$403.1M−11%
- Meta−$425.4M−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |